DSpace at RU >

Browsing by Author Cuenca-Estrella, M.

Full Text	Issue Date	Title	Author(s)
	2012	ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases.	Ullman, A.J.; Cornely, O.A.; Donnelly, P., et al
	2012	ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.	Cornely, O.A.; Bassetti, M.; Calandra, T, et al
	2012	ESCMID guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.	Lortholary, O.; Petrikkos, G.; Akova, M., et al
	2012	ESCMID guideline for the diagnosis and management of Candida diseases 2012:adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).	Ullmann, A.J.; Akova, M.; Herbrecht, R., et al
	2012	ESCMID guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures	Cuenca-Estrella, M.; Verweij, P.E.; Arendrup, M.C., et al
	2012	ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.	Hope, W.W.; Castagnola, E.; Groll, A.H., et al
	2010	EUCAST breakpoints for antifungals.	Rodriguez-Tudela, J.L.; Arendrup, M.C.; Cuenca-Estrella, M., et al
	2011	EUCAST Technical note on Amphotericin B.	Lass-Florl, C.; Arendrup, M.C.; Rodriguez-Tudela, J.L., et al
	2011	EUCAST technical note on anidulafungin	Arendrup, M.C.; Rodriguez-Tudela, J.L.; Lass-Florl, C., et al
	2012	EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.	Arendrup, M.C.; Cuenca-Estrella, M.; Lass-Flörl, C., et al
	2008	EUCAST technical note on fluconazole	Rodriquez Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C., et al
	2011	EUCAST technical note on posaconazole	Arendrup, M.C.; Cuenca-Estrella, M.; Donnelly, J.P., et al
	2012	EUCAST technical note on the EUCAST definitive doucment EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST.).	Arendrup, M.C.; Cuenca-Estrella, M.; Lass-Flörl, C., et al
	2008	EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.	Rodriquez Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C., et al
	2008	EUCAST Technical Note on voriconazole.	Rodriguez-Tudela, J.L.; Donnelly, J.P.; Arendrup, M.C., et al
	2011	European expert opinion on the management of invasive candidiasis in adults	Kullberg, B.J.; Verweij, P.E.; Akova, M., et al
	2011	Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens	White, P.L.; Mengoli, C.; Bretagne, S., et al
	2004	Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.	Odds, F.C.; Motyl, M.; Andrade, R., et al
	2005	International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.	Espinel-Ingroff, A.; Barchiesi, F.; Cuenca-Estrella, M., et al
	2007	A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.	Mellado, E.; Garcia-Effron, G.; Alcazar-Fuoli, L., et al